Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,600.00
Bid: 1,598.00
Ask: 1,598.50
Change: -4.50 (-0.28%)
Spread: 0.50 (0.031%)
Open: 1,613.00
High: 1,613.00
Low: 1,589.00
Prev. Close: 1,604.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

Wed, 01st May 2024 16:56

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

The FTSE 100 index closed down 22.89 points, 0.3%, at 8,121.24. The FTSE 250 ended down 38.80 points, 0.2%, at 19,926.59, and the AIM All-Share closed up 4.24 points, 0.6%, at 764.98.

The Cboe UK 100 ended down 0.3% at 811.07, the Cboe UK 250 closed down 0.4% at 17,230.04, and the Cboe Small Companies ended up 0.2% at 15,762.48.

Financial markets in Paris and Frankfurt are closed on Wednesday.

The Fed announces its latest interest rate decision at 1900 BST. A press conference with Chair Jerome Powell follows half an hour later.

"It's decision day on interest rates in the US and while the Federal Reserve is almost certain to stick with the status quo, there will be considerable interest in the accompanying commentary. Will markets have to get used to the idea of zero cuts in 2024, having started the year with hopes for rates to be materially lowered?" said AJ Bell's Russ Mould.

Before the Fed decision, there has been a flurry of US data.

The US private sector added more jobs than expected last month, numbers from payroll firm ADP showed.

According to the latest ADP tracker, private employers added 192,000 jobs in April, rising from 184,000 in March. The March reading was downwardly revised from an initially reported 208,000. The latest reading beat the FXStreet cited consensus of 175,000.

The US manufacturing sector was stable in April, purchasing managers' index survey results from S&P Global confirmed on Wednesday, but data from the Institute for Supply Management showed the sector fell into contraction.

The S&P Global US manufacturing PMI posted in line with the 50.0 no-change mark in April to point to stable business conditions at the start of the second quarter. The reading was down from 51.9 in March and signalled an end to a three-month sequence of improving operating conditions.

The ISM PMI reported that economic activity in the manufacturing sector contracted in April after one month of expansion following 16 consecutive months of contraction.

The ISM PMI for manufacturing reading slipped to 49.2 points in April from 50.3 in March.

Stocks in New York were mixed at the London equities close. The DJIA was up 0.2%, though the S&P 500 index and Nasdaq Composite were down 0.4% and 0.5%, respectively.

The pound was quoted at USD1.2487 at the London equities close Wednesday, down compared to USD1.2523 at the close on Tuesday. The euro stood at USD1.0679 at the European equities close Wednesday, lower against USD1.0690 at the same time on Tuesday.

Against the yen, the dollar was trading at JPY157.72, up compared to JPY157.44 late Tuesday.

In the FTSE 100, Haleon lost 3.1%.

The Surrey, England-based consumer health arm, spun out of GSK PLC, backed its annual guidance and reported a "solid" quarter.

Revenue declined 2.2% on-year to GBP2.92 billion in the three months that ended March 31, as revenue for Haleon's Pain Relief and Respiratory Health units fell amid a weaker Covid season in China compared to a year ago.

Cost of sales were reduced by 5.7% to GBP1.08 billion from GBP1.15 billion, helping pretax profit to grow by 8.9% to GBP590 million from GBP542 million.

On the other hand, GSK rose 1.6%.

The London-based pharmaceutical maker said revenue in the first-quarter of the year was up 5.9% to GBP7.36 billion from GBP6.95 billion a year prior.

Pretax profit, however, weakened 29% to GBP1.36 billion from GBP1.91 billion.

In the FTSE 250, Aston Martin lost 6.8%, after a disappointing trading update.

The company reported 945 vehicle sales in the first quarter, down 26% from 1,269 a year before.

Pretax loss widened 87% to GBP138.8 million from GBP74.2 million.

Executive Chair Lawrence Stroll said: "2024 is a year of immense product transformation at Aston Martin, with the introduction of four new models to the market before the end of the year. Our first quarter performance reflects this expected period of transition, as we ceased production and delivery of our outgoing core models ahead of the ramp up in production of the new Vantage, upgraded DBX707 and our upcoming V12 flagship sports car which we've confirmed today. As part of our ongoing programme of ultra-exclusive models, we will deliver a new Special in the fourth quarter of the year."

On AIM, Trinity Exploration & Production rose 53%. Touchstone Exploration shares fell 4.5%.

Touchstone Exploration said it reached an agreement to buy Trinity Exploration & Production.

The Trinidad & Tobago-focused oil exploration and production companies aim to become "a leading Trinidadian operator of scale," according to Touchstone, which calls itself the largest independent onshore oil and natural gas producer in Trinidad.

The all-share agreement values Trinity at GBP24.1 million.

Brent oil was quoted at USD83.78 a barrel at the London equities close Wednesday, down from USD86.42 late Tuesday.

Gold was quoted at USD2,308.30 an ounce at the London equities close Wednesday, up against USD2,298.10 at the close on Tuesday.

In Thursday's UK corporate calendar, has first quarter results from Endeavour Mining, Shell, and Standard Chartered.

The economic calendar for Thursday has manufacturing PMIs from Germany and the eurozone. At 1330 BST, there is the weekly US initial jobless claims, as well as trade balance data.

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
11 Jun 2024 14:31

Zantac litigation fears overdone at GSK, says Shore Capital

(Sharecast News) - Volatile moves in GSK's share price are likely to persist in the near term as a result of ongoing Zantac-related litigation, but the long-term investment case is "still appealing", according to Shore Capital, which kept a 'buy' rating on the stock.

Read more
11 Jun 2024 09:32

TOP NEWS: GSK takes first steps to appeal Zantac ruling in Delaware

(Alliance News) - GSK PLC on Tuesday said it has taken the first steps to seek appeal of a ruling by the Delaware Superior Court in regard to its discontinued heartburn drug Zantac.

Read more
11 Jun 2024 09:12

LONDON MARKET OPEN: FTSE 100 up; UK unemployment rises to 4.4%

(Alliance News) - Stock prices in London opened higher on Tuesday, after a difficult day for markets on Monday amid the EU election fallout.

Read more
11 Jun 2024 07:52

LONDON BRIEFING: FTSE 100 called up despite unemployment rise

(Alliance News) - The FTSE 100 in London was called to open higher on Tuesday, after data showed that unemployment in the UK unexpectedly rose.

Read more
11 Jun 2024 07:22

GSK launches appeal to recent Zantac ruling

(Sharecast News) - GSK has started the process of appealing a recent decision by the Delaware Superior Court regarding the ongoing Zantac, or ranitidine, litigation, it announced on Tuesday.

Read more
11 Jun 2024 00:32

GSK asks to appeal Delaware ruling allowing Zantac cases to go forward

June 10 (Reuters) -

Read more
10 Jun 2024 22:49

Latest trial over Zantac cancer claims called off as plaintiff drops case

June 10 (Reuters) - A woman who claimed in a lawsuit that GSK's discontinued heartburn drug Zantac caused her breast cancer dropped her case shortly before it was set to go to trial in Illinois state court on Monday, the company announced.

Read more
10 Jun 2024 19:00

TOP NEWS: GSK welcomes dismissal of Zantac case in Illinois

(Alliance News) - GSK PLC on Monday welcomed the dismissal of a case in the US concerning the heartburn drug, Zantac, which was due to start on Monday.

Read more
10 Jun 2024 12:42

EU to secure 40 million avian flu vaccines for 15 countries - officials

BRUSSELS, June 10 (Reuters) - The EU will sign a contract on Tuesday to secure over 40 million doses of a preventative avian flu vaccine for 15 countries with the first shipments heading to Finland, EU officials said on Monday.

Read more
10 Jun 2024 08:39

GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV

(Alliance News) - GSK PLC on Monday announced that the US Food & Drug Administration has approved an expanded age indication for its respiratory syncytial virus vaccine.

Read more
10 Jun 2024 07:37

LONDON BRIEFING: FTSE called down amid political uncertainty in EU

(Alliance News) - Stocks in London are called to open lower on Monday, setting off the week on the backfoot, with eyes on the US Federal Reserve's latest interest rate decision.

Read more
10 Jun 2024 07:17

GSK's Arexvy vaccine approved for wider age range

(Sharecast News) - US regulators have approved the use of GSK's Arexvy vaccine for a younger age group, the biopharma group announced on Monday.

Read more
7 Jun 2024 19:34

What to know about bird flu in dairy cows and the risk to humans

CHICAGO, June 7 (Reuters) - The outbreak of bird flu in U.S. dairy cows has now been confirmed in Minnesota and Iowa, bringing to 11 the total number of affected states, which have been encouraged to ramp up testing efforts at the request of government officials.

Read more
5 Jun 2024 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Read more
3 Jun 2024 17:20

European shares kick-off June on a high note in anticipation of ECB rate cut

GSK tumbles as Zantac lawsuits allowed to proceed

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.